UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

Annals of the rheumatic diseases, 2011-04, Vol.70 (4), p.616-623

2011

Volltextzugriff (PDF)

Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study

Osteoporosis international, 2019-01, Vol.30 (1), p.221-229

2019

Volltextzugriff (PDF)

CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2015-12, Vol.67 (12), p.3226-3233

2015

Volltextzugriff (PDF)

Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance

Annals of the Rheumatic Diseases, 2015-12, Vol.74 (12), p.2107-2116

2015

Volltextzugriff (PDF)

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

Annals of the rheumatic diseases, 2011-11, Vol.70 (11), p.1895-1904

2011

Volltextzugriff (PDF)

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)

Clinical microbiology and infection, 2018-06, Vol.24, p.S21-S40

2018

Volltextzugriff (PDF)

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

Journal of autoimmunity, 2015-08, Vol.62, p.67-74

2015

Volltextzugriff (PDF)

Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells

Annals of the rheumatic diseases, 2001-11, Vol.60 (11), p.1007-1010

Mariette, X

2001

Volltextzugriff (PDF)

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.977-985

2016

Volltextzugriff (PDF)

Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan‐European Registry Analysis

Arthritis & rheumatology (Hoboken, N.J.), 2016-06, Vol.68 (6), p.1346-1352

2016

Volltextzugriff (PDF)

Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.96-104

2017

Volltextzugriff (PDF)

Childhood-onset of primary Sjögren’s syndrome: phenotypic characterization at diagnosis of 158 children

Rheumatology (Oxford, England), 2021-10, Vol.60 (10), p.4558-4567

2021

Volltextzugriff (PDF)

Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials

Annals of the rheumatic diseases, 2015-01, Vol.74 (1), p.96-103

2015

Volltextzugriff (PDF)

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry

Annals of the rheumatic diseases, 2010-02, Vol.69 (2), p.400-408

2010

Volltextzugriff (PDF)

Tumour necrosis factor blocking agents in refractory adult Still's disease: an observational study of 20 cases

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.262-266

Fautrel, B

2005

Volltextzugriff (PDF)

OP0287 IMMUNOMODULATORY THERAPIES FOR SEVERE FORMS OF COVID-19: A SYSTEMATIC LITERATURE REVIEW TO INFORM EULAR POINTS TO CONSIDER

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.175-175

2021

Volltextzugriff (PDF)

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2015-08, Vol.67 (8), p.2176-2184

2015

Volltextzugriff (PDF)

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome

Annals of the rheumatic diseases, 2003-02, Vol.62 (2), p.168-171

2003

Volltextzugriff (PDF)

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1815-1819

2012

Volltextzugriff (PDF)

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab

Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.875-877

2012

Volltextzugriff (PDF)

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry

Arthritis care & research (2010), 2010-12, Vol.62 (12), p.1787-1795

2010

Volltextzugriff (PDF)

Autoimmune and inflammatory disorders and risk of malignant lymphomas – an update

Journal of internal medicine, 2008-12, Vol.264 (6), p.514-527

2008

Volltextzugriff (PDF)

Tumour necrosis factor α blocking agents in refractory adult Still’s disease: an observational study of 20 cases

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.262-266

2005

Volltextzugriff (PDF)

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren’s syndrome

Annals of the rheumatic diseases, 2007-01, Vol.66 (1), p.23-27

2007

Volltextzugriff (PDF)

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (6), p.1108-1113

2016

Volltextzugriff (PDF)

1 – 25 von 845

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(665)
Mit Volltextzugriff
(630)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(238)
Science & Technology
(233)
Life Sciences & Biomedicine
(219)
Female
(143)
Male
(139)
Middle Aged
(136)
Rheumatology
(129)
Adult
(105)
Aged
(95)
Medicin Och Hälsovetenskap
(90)
Biological And Medical Sciences
(89)
Medical Sciences
(86)
Rheumatoid Arthritis
(81)
Life Sciences
(70)
Treatment Outcome
(55)
Patients
(51)
Sjogren's Syndrome
(48)
Antirheumatic Agents - Therapeutic Use
(40)
Arthritis, Rheumatoid - Drug Therapy
(38)
Risk Factors
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of The Rheumatic Diseases
(266)
Revue Du Rhumatisme
(112)
La Revue De Medecine Interne
(59)
Rheumatology
(21)
La Presse Médicale
(14)
Poster Presentations
(14)
Arthritis And Rheumatism
(13)
Clinical And Experimental Rheumatology
(13)
Arthritis & Rheumatology
(8)
Blood
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study

CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome

Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan‐European Registry Analysis

Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study

Childhood-onset of primary Sjögren’s syndrome: phenotypic characterization at diagnosis of 158 children

Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry

Tumour necrosis factor blocking agents in refractory adult Still's disease: an observational study of 20 cases

OP0287 IMMUNOMODULATORY THERAPIES FOR SEVERE FORMS OF COVID-19: A SYSTEMATIC LITERATURE REVIEW TO INFORM EULAR POINTS TO CONSIDER

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry

Autoimmune and inflammatory disorders and risk of malignant lymphomas – an update

Tumour necrosis factor α blocking agents in refractory adult Still’s disease: an observational study of 20 cases

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren’s syndrome

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry

Suchergebnisse filtern